Cavotricuspid isthmus ablation and atrial fibrillation.

[1] Herskowitz A, Tzyy-Choou WU, Willoughby SB et al. Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. J Am Coll Cardiol 1994; 24: 1025–32. [2] Monsuez JJ, Kinney EL, Vittecoq D et al. Comparison among acquired immune deficiency syndrome patients with and without clinical evidence of cardiac disease. Am J Cardiol 1988; 62: 1311–3. [3] Henry K, Melroe H, Huebsch J et al. Severe premature coronary artery disease with protease inhibitors. Lancet 1998; 351: 1328. [4] Vittecoq D, Escaut L, Monsuez JJ. Vascular complications associated with use of HIV protease inhibitors. Lancet 1998; 351: 1959. [5] Gallet B, Pulik M, Genet P, Chedin P, Hiltgen M. Vascular complications associated with use of HIV protease inhibitors. Lancet 1998; 351: 1958–9. [6] Heidenreich PA, Eisenberg MA, Kee LL et al. Pericardial effusion in AIDS: incidence and survival. Circulation 1995; 92: 3229–34. [7] Yunis N, Stone VE. Cardiac manifestations of HIV/AIDS. JAIDS 1998; 18: 145–54. [8] Pierard D, Telenti A, Sudre P et al. Atherogenic dyslipidemia in HIVinfected individuals treated with protease inhibitors. Circulation 1999; 100: 700–5. doi:10.1053/euhj.2000.2325, available online at http://www.idealibrary.com on